Development and prospects of fecal microbiota transplantation

doi:10.3785/j.issn.1008-9292.2019.06.16

J Zhejiang Univ (Med Sci)

2019, Vol. 48

Issue (3): 342-346 DOI: 10.3785/j.issn.1008-9292.2019.06.16

Development and prospects of fecal microbiota transplantation

HU Yue(

),LYU Bin*(

)

Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310006, China

Download:

HTML( 15 )

PDF(889KB)
Export: BibTeX | EndNote (RIS)

Key words： Intestines/microbiology Fecal microbiota transplantation Clostridium difficile Colitis, ulcerative Irritable bowel syndrome Drug resistance, multiple Obesity Congresses

Received: 02 June 2019 Published: 04 September 2019

CLC:	R574
	Q935

Corresponding Authors: LYU Bin E-mail: huyue@zcmu.edu.cn;lvbin@medmail.com.cn

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HU Yue
	LYU Bin

Cite this article:

HU Yue, LYU Bin. Development and prospects of fecal microbiota transplantation. J Zhejiang Univ (Med Sci), 2019, 48(3): 342-346.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2019.06.16 OR http://www.zjujournals.com/med/Y2019/V48/I3/342


[1]	GUPTA A , KHANNA S . Fecal microbiota transplantation[J]. JAMA, 2017, 318 (1): 102 doi: 10.1001/jama.2017.6466

[2]	VINDIGNI S M , SURAWICZ C M . Fecal microbiota transplantation[J]. Gastroenterol Clin North Am, 2017, 46 (1): 171- 185 doi: 10.1016/j.gtc.2016.09.012

[3]	LYNCH S V , PEDERSEN O . The human intestinal microbiome in health and disease[J]. N Engl J Med, 2016, 375 (24): 2369- 2379 doi: 10.1056/NEJMra1600266

[4]	HE Z , LI P , ZHU J et al. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn's disease complicated with inflammatory mass[J]. Sci Rep, 2017, 7 (1): 4753 doi: 10.1038/s41598-017-04984-z

[5]	ROSSEN N G , FUENTES S , VAN DER SPEK M J et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis[J]. Gastroenterology, 2015, 149 (1): 110- 118 doi: 10.1053/j.gastro.2015.03.045

[6]	PARAMSOTHY S , KAMM M A , KAAKOUSH N O et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis:a randomised placebo-controlled trial[J]. Lancet, 2017, 389 (10075): 1218- 1228 doi: 10.1016/S0140-6736(17)30182-4

[7]	JOHNSEN P H , HILPVSCH F , CAVANAGH J P et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome:a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial[J]. Lancet Gastroenterol Hepatol, 2018, 3 (1): 17- 24 doi: 10.1016/S2468-1253(17)30338-2

[8]	TIAN H , DING C , GONG J et al. Treatment of slow transit constipation with fecal microbiota transplantation:a pilot study[J]. J Clin Gastroenterol, 2016, 50 (10): 865- 870 doi: 10.1097/MCG.0000000000000472

[9]	REN Y D , YE Z S , YANG L Z et al. Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy[J]. Hepatology, 2017, 65 (5): 1765- 1768 doi: 10.1002/hep.29008

[10]	BAJAJ J S , KASSAM Z , FAGAN A et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy:a randomized clinical trial[J]. Hepatology, 2017, 66 (6): 1727- 1738 doi: 10.1002/hep.29306

[11]	VRIEZE A , VAN NOOD E , HOLLEMAN F et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J]. Gastroenterology, 2012, 143 (4): 913- 6 doi: 10.1053/j.gastro.2012.06.031

[12]	KAKIHANA K , FUJIOKA Y , SUDA W et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut[J]. Blood, 2016, 128 (16): 2083- 2088 doi: 10.1182/blood-2016-05-717652

[13]	HE Z , CUI B T , ZHANG T et al. Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease:The first report[J]. World J Gastroenterol, 2017, 23 (19): 3565- 3568 doi: 10.3748/wjg.v23.i19.3565

[14]	SURAWICZ C M , BRANDT L J , BINION D G et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections[J]. Am J Gastroenterol, 2013, 108 (4): 478- 498 doi: 10.1038/ajg.2013.4

[15]	MULLISH B H , QURAISHI M N , SEGAL J P et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications:joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines[J]. Gut, 2018, 67 (11): 1920- 1941 doi: 10.1136/gutjnl-2018-316818

[16]	MCDONALD L C , GERDING D N , JOHNSON S et al. Clinical practice guidelines for clostridium difficile infection in adults and children:2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)[J]. Clin Infect Dis, 2018, 66 (7): 987- 994 doi: 10.1093/cid/ciy149

[17]	SINGH S , FEUERSTEIN J D , BINION D G et al. AGA technical review on the management of mild-to-moderate ulcerative colitis[J]. Gastroenterology, 2019, 156 (3): 769- 808 doi: 10.1053/j.gastro.2018.12.008

[18]	MOAYYEDI P , SURETTE M G , KIM P T et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial[J]. Gastroenterology, 2015, 149 (1): 102- 109 doi: 10.1053/j.gastro.2015.04.001

[19]	KASSINEN A , KROGIUS-KURIKKA L , M?KIVUOKKO H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects[J]. Gastroenterology, 2007, 133 (1): 24- 33 doi: 10.1053/j.gastro.2007.04.005

[20]	BHATTARAI Y , MUNIZ PEDROGO D A , KASHYAP P C . Irritable bowel syndrome:a gut microbiota-related disorder?[J]. Am J Physiol Gastrointest Liver Physiol, 2017, 312 (1): G52- G62 doi: 10.1152/ajpgi.00338.2016

[21]	XU D , CHEN V L , STEINER C A et al. Efficacy of fecal microbiota transplantation in irritable bowel syndrome:a systematic review and meta-analysis[J]. Am J Gastroenterol, 2019, 114 (7): 1043- 1050 doi: 10.14309/ajg.0000000000000198

[1]	FAN Yihong, LYU Bin. Research frontier of inflammatory bowel disease[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 334-341.

[2]	QI Xiaohua,WANG Xinyi,HE Fan,LIU Biyao,ZHANG Tao,LI Fudong,ZHAI Yujia,LIN Junfen. Risk assessment for emergency events of infectious disease in outlying areas of large-scale activities[J]. J Zhejiang Univ (Med Sci), 2018, 47(2): 124-130.

[3]	ZHENG Qi,LU Meiping. Focus on pediatric rheumatic and immune diseases[J]. J Zhejiang Univ (Med Sci), 2018, 47(2): 213-217.

[4]	LU Shen,WANG Qingqing. Focus on the 14th International Symposium on Dendritic Cells[J]. J Zhejiang Univ (Med Sci), 2017, 46(1): 106-109.

[5]	Wei Jie-ping, Huang He. Highlights of the 19th Congress of Asia-Pacific Blood and Marrow Transplantation[J]. J Zhejiang Univ (Med Sci), 2015, 44(1): 112-115.

[6]	CHEN Xin-hua, ZHANG Xue-ming, YIN Sheng-yong, ZHENG Shu-sen. Bioelectric-technology in tumor minimally invasive therapy——from the 11th International Bioelectrics Symposium[J]. J Zhejiang Univ (Med Sci), 2015, 44(1): 108-111.

[7]	WANG Kan, et al. Highlights from 1st AGA professional conference in China[J]. J Zhejiang Univ (Med Sci), 2014, 43(6): 728-730.

[8]	CHEN Lianhui，LIANG Li，FU Junfen，ZHU Weifen，WANG Chunlin，HUANG Ke，FANG Yan. Comparison of clinical application of two definitions of metabolic syndrome in children and adolescents[J]. J Zhejiang Univ (Med Sci), 2013, 42(4): 375-.

[9]	LIN Hu，FU Junfen，CHEN Xuefeng，HUANG Ke，WU Wei，LIANG Li. Early identification of impaired renal function in obese children with non-alcoholic fatty liver disease[J]. J Zhejiang Univ (Med Sci), 2013, 42(4): 381-.

[10]	ZHU Mingqiang，FU Junfen，LIANG Li，GONG Cunxiu，XIONG Feng，LIU Geli，LUO Fei. Epidemiologic study on current pubertal development in Chinese school-aged children [J]. J Zhejiang Univ (Med Sci), 2013, 42(4): 396-.

[11]	. Screening of differentially expressed genes during adipocyte differentiation by suppression subtractive hybridization technique[J]. J Zhejiang Univ (Med Sci), 2012, 41(3): 267-273.

[12]	. Research progress on nicotinamide phosphoribosyl transferase involved in aging and age-related diseases[J]. J Zhejiang Univ (Med Sci), 2011, 40(6): 680-684.

Viewed

Full text

Abstract

Cited

Shared

Discussed